Article
Group Testing Can Improve the Cost-Efficiency of Prospective-Retrospective Biomarker Studies
2021-01-18
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Cancer treatment is increasingly dependent on biomarkers for prognostication and treatment selection. Potential biomarkers are frequently evaluated in prospective-retrospective studies in which biomarkers are measured retrospectively on archived specimens after completion of prospective clinical trials. In light of the high costs of some assays, random sampling...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 92278267-d1d0-547f-b091-85e740933ab9
- DOI
- 10.21203/rs.3.rs-51687/v2
